BMY vs CAH
BMY vs CAH — side by side. Price, change, valuation.
BMY
Bristol-Myers Squibb Company
$62.56+0.76%
NYSE
CAH
Cardinal Health, Inc.
$229.35+0.58%
NYQ
| Metric | BMY | CAH | Side by side |
|---|---|---|---|
| Last price | $62.56 | $229.35 | −166.79 |
| Day Δ % | 0.76 | 0.58 | +0.18pp |
| Market cap | not on file | not on file | not on file |
| P/E (fwd) | not on file | not on file | not on file |
| P/E (trailing) | not on file | not on file | not on file |
| Implied move | not on file | not on file | not on file |
| Put/Call OI | not on file | not on file | not on file |
| Analyst target (mean) | not on file | not on file | not on file |
Descriptor deltas are comparative facts (higher / lower), not a recommendation. A metric absent for either company is shown as “not on file” — never filled with a placeholder.